Australia markets closed

Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.4039-0.0131 (-3.14%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 6.82M
Enterprise value 2.45M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.68
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.60

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-64.25%
S&P500 52-week change 325.59%
52-week high 32.7500
52-week low 30.3500
50-day moving average 30.4158
200-day moving average 30.5276

Share statistics

Avg vol (3-month) 348.14k
Avg vol (10-day) 327.74k
Shares outstanding 516.89M
Implied shares outstanding 617.28M
Float 89.55M
% held by insiders 145.11%
% held by institutions 11.82%
Shares short (15 Apr 2024) 473k
Short ratio (15 Apr 2024) 41.01
Short % of float (15 Apr 2024) 40.71%
Short % of shares outstanding (15 Apr 2024) 40.43%
Shares short (prior month 15 Mar 2024) 465.87k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-50.43%
Return on equity (ttm)-112.37%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -5.89M
Net income avi to common (ttm)-6.59M
Diluted EPS (ttm)-0.4400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.46M
Total cash per share (mrq)0.32
Total debt (mrq)1.09M
Total debt/equity (mrq)26.82%
Current ratio (mrq)5.37
Book value per share (mrq)0.25

Cash flow statement

Operating cash flow (ttm)-5.58M
Levered free cash flow (ttm)-2.75M